Form 4 for BSX Boston Scientific
Accepted 2021-07-27 00:00:00 ET · period of report 2021-07-27 · accession 0001225208-21-010900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-27 | 2021-07-27 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Interven Cardio | S - Sale+OE | $45.00 | -105.5K | 203.6K | -34% | -$4.75M |
| D | 2021-07-27 | 2021-07-27 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Interven Cardio | M - OptEx | $6.28 | +70.3K | 309.1K | +29% | +$441.5K |
| D | 2021-07-27 | 2021-05-06 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Interven Cardio | G - Gift | $0.00 | -12.0K | 238.8K | -5% | $0 |
| D | 2021-07-27 | 2021-07-27 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Interven Cardio | M - OptEx | $0.00 | -70.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-27 | S | D | 105,490 | $45.00 | 203,596 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at $45.00 and $45.02. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2021-07-27 | M | A | 70,306 | $6.28 | 309,086 | D | — | — | |
| 3 | Common | Common Stock | 2021-05-06 | G | D | 12,000 | $0.00 | 238,780 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-07-27 | M | D | 70,306 | $0.00 | 0 | D | $6.28 · — to 2022-02-27 | 70,306 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. |